Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma
Conditions
- Anaplastic Large Cell Lymphoma
- Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
- Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Romidepsin
- DRUG: Venetoclax
Sponsor
City of Hope Medical Center
Collaborators